MedTrace Logo

Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE

NCT01895010 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2013-07-10

No results posted yet for this study

Summary

Observation on acupoint electric stimulation combined with tropisetron in preventing and treating nausea and vomiting and improving the patient's appetite after TACE for primary or metastatic liver cancer patients.

Conditions

Interventions

DEVICE

acupoint electric stimulation

acupoint electric stimulation combined with tropisetron 6mg before TACE

DRUG

tropisetron

only tropisetron 6mg before TACE

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Xiaoyan Zhu, Doc · Shanghai Cancer Centre, Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01895010 on ClinicalTrials.gov